Literature DB >> 19444643

Proteome analysis of haptoglobin in cerebrospinal fluid of neuromyelitis optica.

Shumei Bai1, Shilian Liu, Xuxiao Guo, Zhaoyu Qin, Banqin Wang, Xiaohong Li, Yanjiang Qin.   

Abstract

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. Although diagnostic criteria for NMO are available, there is still a need for biomarkers, predicting disease development and progression to improve individually tailored treatment. CSF proteins were separated by two-dimensional electrophoresis and identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). The interaction between these proteins was further analyzed by Pathway Studio software. Seven protein spots in CSF were significantly altered in NMO patients compared with controls. Identification made by mass spectrometry revealed that the most significant protein was haptoglobin, which was increased in the NMO gels. The subsequent ELISA test were performed to validate it, which confirmed the results of proteomic analysis. Protein network was built, which showed some biological interactions among the seven proteins. These results support a correlation between the level of haptoglobin and NMO. Haptoglobin may be a potential useful biomarker for diagnosis or a medicine target for treatment of NMO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444643     DOI: 10.1007/s11033-009-9574-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  21 in total

1.  TNF-induced haptoglobin release from human neutrophils: pivotal role of the TNF p55 receptor.

Authors:  N Berkova; C Gilbert; S Goupil; J Yan; V Korobko; P H Naccache
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Proteomics analysis of phosphotyrosyl-proteins in human lumbar cerebrospinal fluid.

Authors:  Xianglin Yuan; Dominic M Desiderio
Journal:  J Proteome Res       Date:  2003 Sep-Oct       Impact factor: 4.466

3.  Cerebrospinal fluid findings in Devic's neuromyelitis optica.

Authors:  M Zaffaroni
Journal:  Neurol Sci       Date:  2004-11       Impact factor: 3.307

4.  High CSF neurofilament heavy chain levels in neuromyelitis optica.

Authors:  I Miyazawa; I Nakashima; A Petzold; K Fujihara; S Sato; Y Itoyama
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

Review 5.  Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.

Authors:  A A Argyriou; N Makris
Journal:  Acta Neurol Scand       Date:  2008-03-11       Impact factor: 3.209

6.  Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.

Authors:  I Rite; S Argüelles; J L Venero; S García-Rodriguez; A Ayala; J Cano; A Machado
Journal:  J Neurosci Res       Date:  2007-12       Impact factor: 4.164

7.  Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.

Authors:  V Chamoun; A Zeman; K Blennow; P Fredman; A Wallin; G Keir; G Giovannoni; E J Thompson
Journal:  J Neurol Sci       Date:  2001-01-01       Impact factor: 3.181

8.  Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation.

Authors:  O Gaillard; A Gervais; D Meillet; E Plassart; B Fontaine; O Lyon-Caen; J Delattre; E Schuller
Journal:  J Neurol Sci       Date:  1998-06-30       Impact factor: 3.181

9.  Antioxidant role of human haptoglobin.

Authors:  Chi Feng Tseng; Chia Ching Lin; Hsing Yi Huang; Huei Chun Liu; Simon J T Mao
Journal:  Proteomics       Date:  2004-08       Impact factor: 3.984

10.  ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity.

Authors:  Márcia Almeida Liz; Cláudio M Gomes; Maria João Saraiva; Mónica Mendes Sousa
Journal:  J Lipid Res       Date:  2007-08-10       Impact factor: 5.922

View more
  5 in total

Review 1.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

2.  Proteomic analysis of cerebrospinal fluid in canine cervical spondylomyelopathy.

Authors:  Paula Martin-Vaquero; Ronaldo C da Costa; Matthew J Allen; Sarah A Moore; Jeremy K Keirsey; Kari B Green
Journal:  Spine (Phila Pa 1976)       Date:  2015-05-01       Impact factor: 3.468

3.  Characterization of acute renal allograft rejection by proteomic analysis of renal tissue in rat.

Authors:  Gang Chen; Jing-Bin Huang; Jie Mi; Yun-Feng He; Xiao-Hou Wu; Chun-Li Luo; Si-Min Liang; Jia-Bing Li; Ya-Xiong Tang; Jie Li
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

4.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13

5.  Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease.

Authors:  Yen-Chu Huang; Yih-Ru Wu; Mu-Yun Tseng; Yi-Chun Chen; Sen-Yung Hsieh; Chiung-Mei Chen
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.